Pharmaceutical composition containing an arylalkylamine compound
The present invention provides a pharmaceutical composition and the like comprising (4-{(3S)-3-[(1R)-1-(naphthalen-1-yl)ethylamino]pyrrolidin-1-yl}phenyl)acetic acid (Compound A) or a pharmacologically acceptable salt thereof and a diluent.
1. A pharmaceutical composition, comprising:
(4-{(3S)-3-[(1R)-1-(naphthalen-1-yl)ethylamino]pyrrolidin-1-yl}phenyl)acetic acid (Compound A) or a pharmacologically acceptable salt thereof;
at least one diluent selected from the group consisting of a sugar, a sugar alcohol, a cellulose derivative, a starch derivative, and an inorganic salt; and
at least one basic additive selected from the group consisting of calcium carbonate, calcium silicate, and magnesium aluminometasilicate.
2. The pharmaceutical composition of claim 1 , wherein the diluent is at least one selected from the group consisting of lactose, white sugar, maltose, sucrose, mannitol, sorbitol, erythritol, maltitol, xylitol, glucose, crystalline cellulose, corn starch, potato starch, calcium monohydrogen phosphate, calcium dihydrogen phosphate, sodium dihydrogen phosphate and calcium phosphate.
3. The pharmaceutical composition of claim 1 , wherein the diluent is contained in an amount of from 0.1 parts by weight to 99.9 parts by weight per 100 parts by weight of the pharmaceutical composition.
4. The pharmaceutical composition of claim 1 , further comprising:
at least one additive selected from the group consisting of a binder, a disintegrant, a lubricant, a coloring agent and a polishing agent.
5. The pharmaceutical composition of claim 4 , wherein the binder is at least one selected from the group consisting of hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, carboxymethylcellulose, carboxymethylethylcellulose, hydroxypropyl starch, hydroxyethylcellulose, hydroxypropylmethylcellulose acetate succinate, hydroxypropylmethylcellulose phthalate, carboxyvinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol, methacrylate copolymer, macrogol, starch, gelatin, dextrin, pullulan, agar and gum Arabic.
6. The pharmaceutical composition of claim 4 , wherein the disintegrant is at least one selected from the group consisting of croscarmellose sodium, crospovidone, sodium carboxymethyl starch, low-substituted hydroxypropylcellulose, carboxymethylcellulose, carboxymethylcellulose calcium, partially pregelatinized starch and starch.
7. The pharmaceutical composition of claim 4 , wherein the lubricant is at least one selected from the group consisting of magnesium stearate, calcium stearate, talc, glyceryl monostearate, light anhydrous silicic acid, sodium stearyl fumarate and sucrose fatty acid esters.
8. The pharmaceutical composition of claim 4 , wherein the coloring agent is at least one selected from the group consisting of yellow ferric oxide, titanium oxide, talc, ferric oxide, black iron oxide, copper chlorophyll, sodium copper chlorophylline, carbon black, medicinal charcoal, food dye, licorice extract, green tea powder, riboflavin, riboflavin butyrate, riboflavin sodium phosphate, and octyldodecyl myristate.
9. The pharmaceutical composition of claim 4 , wherein the polishing agent is at least one selected from the group consisting of carnauba wax, shellac, beeswax, hardened oil and magnesium stearate.
10. The pharmaceutical composition of claim 4 , wherein the additive is contained in an amount of from 0.1 parts by weight to 99.9 parts by weight per 100 parts by weight of the pharmaceutical composition.
11. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition has a coating film.
12. The pharmaceutical composition of claim 11 , wherein the coating film comprises at least one coating agent selected from the group consisting of a water-soluble polymer, lactose, white sugar, titanium oxide and talc.
13. The pharmaceutical composition of claim 12 , wherein the water-soluble polymer is at least one selected from the group consisting of polyvinyl alcohol-polyethylene glycol graft copolymer, polyvinylpyrrolidone, hypromellose, hydroxypropylcellulose, polyvinyl alcohol, polyvinyl alcohol-acrylic acid-methyl methacrylate copolymer and polyethylene glycol.
14. The pharmaceutical composition of claim 12 , wherein the coating agent is contained in an amount of from 0.1 parts by weight to 100 parts by weight per 100 parts by weight of the coating film.
15. The pharmaceutical composition of claim 11 , wherein the coating film comprises a first coating film comprising a polyvinyl alcohol-polyethylene glycol graft copolymer and a second coating film comprising at least one agent selected from the group consisting of a water-soluble polymer, lactose, white sugar, titanium oxide and talc.
16. The pharmaceutical composition of claim 15 , wherein the second coating film comprises at least one agent selected from the group consisting of a water-soluble polymer, lactose and titanium oxide.
17. The pharmaceutical composition of claim 16 , wherein the second coating film further comprises a coloring agent.
18. The pharmaceutical composition of claim 4 ,
wherein the pharmaceutical composition has a coating film comprising at least one coating agent selected from the group consisting of a water-soluble polymer, lactose, white sugar, titanium oxide and talc, and
the pharmaceutical composition comprises:
from 0.5 to 5.0 parts by weight of the Compound A or a pharmacologically acceptable salt thereof,
from 50.0 to 90.0 parts by weight of the diluent,
from 1.0 to 5.0 parts by weight of the binder,
from 0.5 to 5.0 parts by weight of the basic additive,
from 2.0 to 10.0 parts by weight of the disintegrant,
from 0.5 to 3.0 parts by weight of the lubricant,
from 3.0 to 10.0 parts by weight of the coating agent, and
from 0.1 to 1.0 parts by weight of the coloring agent,
per 100 parts by weight of the pharmaceutical composition.
19. The pharmaceutical composition of claim 1 , which comprises:
from 0.5 to 5.0 parts by weight of the Compound A or a pharmacologically acceptable salt thereof,
from 50.0 to 90.0 parts by weight of the diluent, and
from 0.5 to 5.0 parts by weight of the basic additive,
per 100 parts by weight of the pharmaceutical composition.
20. The pharmaceutical composition of claim 1 , which comprises:
from 0.5 to 5.0 parts by weight of the Compound A or a pharmacologically acceptable salt thereof,
from 85 to 90 parts by weight of the diluent, and
from 0.99 to 3.0 parts by weight of the basic additive,
per 100 parts by weight of the pharmaceutical composition.